ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
10.85
-0.25 (-2.25%)
At close: Apr 28, 2026, 4:00 PM EDT
10.85
0.00 (0.00%)
After-hours: Apr 28, 2026, 6:16 PM EDT

ProMIS Neurosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cost of Revenue
33.3810.647.8816.094.63
Upgrade
Gross Profit
-33.38-10.64-7.88-16.09-4.63
Upgrade
Selling, General & Admin
6.296.195.585.993.66
Upgrade
Operating Expenses
6.296.195.585.993.66
Upgrade
Operating Income
-39.67-16.83-13.46-22.08-8.29
Upgrade
Interest Expense
--0.08-0.2-0.28-0.42
Upgrade
Other Non Operating Income (Expenses)
0.4523.181.254.29-1.08
Upgrade
EBT Excluding Unusual Items
-39.226.28-12.41-18.07-9.79
Upgrade
Other Unusual Items
-0.5-3.5-0.80.01-
Upgrade
Pretax Income
-39.722.78-13.21-18.06-9.79
Upgrade
Net Income
-39.722.78-13.21-18.06-9.79
Upgrade
Net Income to Common
-39.722.78-13.21-18.06-9.79
Upgrade
Shares Outstanding (Basic)
21000
Upgrade
Shares Outstanding (Diluted)
21000
Upgrade
Shares Change (YoY)
65.98%115.26%63.85%29.68%21.55%
Upgrade
EPS (Basic)
-22.612.68-26.87-60.19-42.30
Upgrade
EPS (Diluted)
-22.612.63-26.87-60.19-42.30
Upgrade
Free Cash Flow
-28.12-27.18-10.84-17.04-9.31
Upgrade
Free Cash Flow Per Share
-16.00-25.68-22.05-56.77-40.23
Upgrade
EBITDA
--16.81-13.44-22.07-8.25
Upgrade
D&A For EBITDA
-0.020.020.010.05
Upgrade
EBIT
-39.67-16.83-13.46-22.08-8.29
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.